{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:57:11Z","timestamp":1791053831863,"version":"4.1.0"},"reference-count":79,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with advanced cutaneous T-cell lymphoma (CTCL) exhibit profound defects in cell-mediated immunity. Host immune functions appear to play an integral role in mediating disease-controlling responses in CTCL, therefore we investigated the effects of synthetic oligode-oxynucleotides with CpG motifs (CpG ODN), which have been recognized as immune stimulatory by virtue of activation of dendritic cells (DCs) following binding to Toll-like receptor (TLR) 9. Peripheral blood mononuclear cells (PBMCs) from patients with advanced CTCL (erythroderma with circulating malignant T cells) and healthy volunteers were cultured with either CpG-A or CpG-B ODN. Patients' PBMCs exhibited marked induction of interferon-\u03b1 (IFN-\u03b1) release following culture with CpG-A. Similarly significant activation of NK cells and CD8 T cells occurred as assessed by up-modulation of CD69 expression and by natural killer lytic activity. Nevertheless, the PBMCs of patients exhibited blunted responses to CpG-A compared to healthy volunteers. In such cases, IL-15 was capable of producing levels of NK activation that were superior to CpG-A, while the combined effects of CpG-A plus IL-15 induced maximal activation of NK cells and further enhanced activation of CD8 T cells. These findings have important implications for the potential enhancement of antitumor immunity among patients with advanced CTCL.<\/jats:p>","DOI":"10.1182\/blood-2004-03-1190","type":"journal-article","created":{"date-parts":[[2004,8,25]],"date-time":"2004-08-25T00:13:16Z","timestamp":1093392796000},"page":"4142-4149","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15"],"prefix":"10.1182","volume":"104","author":[{"given":"Maria","family":"Wysocka","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice M.","family":"Benoit","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Newton","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Azzoni","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Montaner","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218315324300_REF1","doi-asserted-by":"crossref","unstructured":"Haynes BF, Bunn P, Mann D, et al. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J Clin Invest. 1981;67: 523-530.","DOI":"10.1172\/JCI110062"},{"key":"2020021218315324300_REF2","doi-asserted-by":"crossref","unstructured":"Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sezary syndrome. Blood. 1996;88: 2385-2409.","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385"},{"key":"2020021218315324300_REF3","doi-asserted-by":"crossref","unstructured":"Rook AH, Heald P. The immunopathogenesis of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9: 997-1010.","DOI":"10.1016\/S0889-8588(18)30054-6"},{"key":"2020021218315324300_REF4","doi-asserted-by":"crossref","unstructured":"Rook AH, Vowels BR, Jaworsky C, Singh A, Lessin SR. The immunopathogenesis of cutaneous T-cell lymphoma: abnormal cytokine production by Sezary T cells. Arch Dermatol. 1993;129: 486-489.","DOI":"10.1001\/archderm.1993.01680250098016"},{"key":"2020021218315324300_REF5","doi-asserted-by":"crossref","unstructured":"Rook AH, Kubin M, Cassin M, et al. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol. 1995;154: 1491-1498.","DOI":"10.4049\/jimmunol.154.3.1491"},{"key":"2020021218315324300_REF6","doi-asserted-by":"crossref","unstructured":"Wood NL, Kitces EN, Blaylock WK. Depressed lymphokine activated killer cell activity in mycosis fungoides: a possible marker for aggressive disease. Arch Dermatol. 1990;126: 907-913.","DOI":"10.1001\/archderm.1990.01670310069009"},{"key":"2020021218315324300_REF7","doi-asserted-by":"crossref","unstructured":"Vowels BR, Lessin SR, Cassin M, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol. 1994;103: 669-673.","DOI":"10.1111\/1523-1747.ep12398454"},{"key":"2020021218315324300_REF8","doi-asserted-by":"crossref","unstructured":"Vowels BR, Rook AH, Cassin M, Zweiman B. Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactions. J Allergy Clin Immunol. 1995;96: 92-96.","DOI":"10.1016\/S0091-6749(95)70037-4"},{"key":"2020021218315324300_REF9","doi-asserted-by":"crossref","unstructured":"Lessin SR, Vowels BR, Rook AH. Th2 cytokine profile in cutaneous T-cell lymphoma. J Invest Dermatol. 1995;105: 855-856.","DOI":"10.1111\/1523-1747.ep12326693"},{"key":"2020021218315324300_REF10","doi-asserted-by":"crossref","unstructured":"Suchin KR, Cassin M, Gottleib SL, et al. Increased interleukin 5 production in eosinophilic Sezary syndrome: regulation by interferon alfa and interleukin 12. J Am Acad Dermatol. 2001;44: 28-32.","DOI":"10.1067\/mjd.2001.109853"},{"key":"2020021218315324300_REF11","doi-asserted-by":"crossref","unstructured":"Wysocka M, Zaki MH, French LE, et al. Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood. 2002;100: 3287-3294.","DOI":"10.1182\/blood-2002-01-0231"},{"key":"2020021218315324300_REF12","doi-asserted-by":"crossref","unstructured":"Rook AH, Yoo EK, Grossman DJ, Kao DM, Fox FE, Niu Z. Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma. Curr Opin Oncol. 1998;10: 170-174.","DOI":"10.1097\/00001622-199803000-00015"},{"key":"2020021218315324300_REF13","doi-asserted-by":"crossref","unstructured":"Vittorio CC, Junkins-Hopkins JM, McGinnis KS, et al. New biologic agents for the treatment of cutaneous T-cell lymphoma. Recent Results Cancer Res. 2002;160: 321-328.","DOI":"10.1007\/978-3-642-59410-6_37"},{"key":"2020021218315324300_REF14","doi-asserted-by":"crossref","unstructured":"Suchin KR, Cucchiara AJ, Gottleib SL, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol. 2002;138: 1054-1060.","DOI":"10.1001\/archderm.138.8.1054"},{"key":"2020021218315324300_REF15","doi-asserted-by":"crossref","unstructured":"Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20: 709-760.","DOI":"10.1146\/annurev.immunol.20.100301.064842"},{"key":"2020021218315324300_REF16","doi-asserted-by":"crossref","unstructured":"Krieg AM. CpG motifs: the active ingredient in bacterial extracts? Nat Med. 2003;9: 831-835.","DOI":"10.1038\/nm0703-831"},{"key":"2020021218315324300_REF17","doi-asserted-by":"crossref","unstructured":"Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408: 740-745.","DOI":"10.1038\/35047123"},{"key":"2020021218315324300_REF18","doi-asserted-by":"crossref","unstructured":"Bauer S, Kirschning CJ, Hacker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A. 2001;98: 9237-9242.","DOI":"10.1073\/pnas.161293498"},{"key":"2020021218315324300_REF19","doi-asserted-by":"crossref","unstructured":"Bauer S, Wagner H. Bacterial CpG-DNA licenses TLR9. Curr Top Microbiol Immunol. 2002;270: 145-154.","DOI":"10.1007\/978-3-642-59430-4_9"},{"key":"2020021218315324300_REF20","doi-asserted-by":"crossref","unstructured":"Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2: 675-680.","DOI":"10.1038\/90609"},{"key":"2020021218315324300_REF21","doi-asserted-by":"crossref","unstructured":"Krug A, Rothenfusser S, Hornung V, et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells. Eur J Immunol. 2001;31: 2154-2163.","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U"},{"key":"2020021218315324300_REF22","doi-asserted-by":"crossref","unstructured":"Rothenfusser S, Tuma E, Endres S, Hartmann G. Plasmacytoid dendritic cells: the key to CpG. Hum Immunol. 2002;63: 1111-1119.","DOI":"10.1016\/S0198-8859(02)00749-8"},{"key":"2020021218315324300_REF23","doi-asserted-by":"crossref","unstructured":"Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A. 1999;96: 9305-9310.","DOI":"10.1073\/pnas.96.16.9305"},{"key":"2020021218315324300_REF24","doi-asserted-by":"crossref","unstructured":"Askew D, Chu RS, Krieg AM, Harding CV. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J Immunol. 2000;165: 6889-6895.","DOI":"10.4049\/jimmunol.165.12.6889"},{"key":"2020021218315324300_REF25","doi-asserted-by":"crossref","unstructured":"Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur J Immunol. 2000;30: 3591-3597.","DOI":"10.1002\/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J"},{"key":"2020021218315324300_REF26","doi-asserted-by":"crossref","unstructured":"Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol. 2001;166: 5000-5007.","DOI":"10.4049\/jimmunol.166.8.5000"},{"key":"2020021218315324300_REF27","doi-asserted-by":"crossref","unstructured":"Miconnet I, Koenig S, Speiser D, et al. CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol. 2002;168: 1212-1218.","DOI":"10.4049\/jimmunol.168.3.1212"},{"key":"2020021218315324300_REF28","doi-asserted-by":"crossref","unstructured":"Lonsdorf AS, Kuekrek H, Stern BV, Boehm BO, Lehmann PV, Tary-Lehmann M. Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity. J Immunol. 2003;171: 3941-3946.","DOI":"10.4049\/jimmunol.171.8.3941"},{"key":"2020021218315324300_REF29","doi-asserted-by":"crossref","unstructured":"Vollmer J, Weeratna R, Payette P, et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol. 2004;34: 251-262.","DOI":"10.1002\/eji.200324032"},{"key":"2020021218315324300_REF30","doi-asserted-by":"crossref","unstructured":"Krug A, Rothenfusser S, Selinger S, et al. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells. J Immunol. 2003;170: 3468-3477.","DOI":"10.4049\/jimmunol.170.7.3468"},{"key":"2020021218315324300_REF31","doi-asserted-by":"crossref","unstructured":"Ortaldo JR, Mantovani A, Hobbs D, Rubinstein M, Pestka S, Herberman RB. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer. 1983;31: 285-289.","DOI":"10.1002\/ijc.2910310306"},{"key":"2020021218315324300_REF32","doi-asserted-by":"crossref","unstructured":"Herberman RB, Ortaldo JR, Mantovani A, Hobbs DS, Kung HF, Pestka S. Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol. 1982;67: 160-167.","DOI":"10.1016\/0008-8749(82)90208-8"},{"key":"2020021218315324300_REF33","doi-asserted-by":"crossref","unstructured":"Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998;8: 591-599.","DOI":"10.1016\/S1074-7613(00)80564-6"},{"key":"2020021218315324300_REF34","doi-asserted-by":"crossref","unstructured":"Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol. 1996;156: 735-741.","DOI":"10.4049\/jimmunol.156.2.735"},{"key":"2020021218315324300_REF35","doi-asserted-by":"crossref","unstructured":"Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001;167: 1179-1187.","DOI":"10.4049\/jimmunol.167.3.1179"},{"key":"2020021218315324300_REF36","doi-asserted-by":"crossref","unstructured":"Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189: 521-530.","DOI":"10.1084\/jem.189.3.521"},{"key":"2020021218315324300_REF37","doi-asserted-by":"crossref","unstructured":"Montoya M, Schiavoni G, Mattei F, et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood. 2002;99: 3263-3271.","DOI":"10.1182\/blood.V99.9.3263"},{"key":"2020021218315324300_REF38","doi-asserted-by":"crossref","unstructured":"Cho SS, Bacon CM, Sudarshan C, et al. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol. 1996; 157: 4781-4789.","DOI":"10.4049\/jimmunol.157.11.4781"},{"key":"2020021218315324300_REF39","doi-asserted-by":"crossref","unstructured":"Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1: 305-310.","DOI":"10.1038\/79747"},{"key":"2020021218315324300_REF40","doi-asserted-by":"crossref","unstructured":"Takaoka A, Hayakawa S, Yanai H, et al. Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature. 2003;424: 516-523.","DOI":"10.1038\/nature01850"},{"key":"2020021218315324300_REF41","doi-asserted-by":"crossref","unstructured":"Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97: 14-32.","DOI":"10.1182\/blood.V97.1.14"},{"key":"2020021218315324300_REF42","doi-asserted-by":"crossref","unstructured":"Bamford RN, Grant AJ, Burton JD, et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994;91: 4940-4944.","DOI":"10.1073\/pnas.91.11.4940"},{"key":"2020021218315324300_REF43","doi-asserted-by":"crossref","unstructured":"Burton JD, Bamford RN, Peters C, et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994;91: 4935-4939.","DOI":"10.1073\/pnas.91.11.4935"},{"key":"2020021218315324300_REF44","doi-asserted-by":"crossref","unstructured":"Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994;264: 965-968.","DOI":"10.1126\/science.8178155"},{"key":"2020021218315324300_REF45","doi-asserted-by":"crossref","unstructured":"Di Santo JP, Kuhn R, Muller W. Common cytokine receptor gamma chain (gamma c)-dependent cytokines: understanding in vivo functions by gene targeting. Immunol Rev. 1995;148: 19-34.","DOI":"10.1111\/j.1600-065X.1995.tb00091.x"},{"key":"2020021218315324300_REF46","doi-asserted-by":"crossref","unstructured":"Asao H, Okuyama C, Kumaki S, et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol. 2001;167: 1-5.","DOI":"10.4049\/jimmunol.167.1.1"},{"key":"2020021218315324300_REF47","doi-asserted-by":"crossref","unstructured":"Fehniger TA, Cooper MA, Caligiuri MA. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev. 2002;13: 169-183.","DOI":"10.1016\/S1359-6101(01)00021-1"},{"key":"2020021218315324300_REF48","doi-asserted-by":"crossref","unstructured":"Williams NS, Klem J, Puzanov IJ, et al. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol Rev. 1998;165: 47-61.","DOI":"10.1111\/j.1600-065X.1998.tb01229.x"},{"key":"2020021218315324300_REF49","doi-asserted-by":"crossref","unstructured":"Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996;87: 2632-2640.","DOI":"10.1182\/blood.V87.7.2632.bloodjournal8772632"},{"key":"2020021218315324300_REF50","doi-asserted-by":"crossref","unstructured":"Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood. 1996;88: 230-235.","DOI":"10.1182\/blood.V88.1.230.230"},{"key":"2020021218315324300_REF51","doi-asserted-by":"crossref","unstructured":"Berard M, Brandt K, Bulfone-Paus S, Tough DF. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol. 2003;170: 5018-5026.","DOI":"10.4049\/jimmunol.170.10.5018"},{"key":"2020021218315324300_REF52","doi-asserted-by":"crossref","unstructured":"Judge AD, Zhang X, Fujii H, Surh CD, Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med. 2002;196: 935-946.","DOI":"10.1084\/jem.20020772"},{"key":"2020021218315324300_REF53","doi-asserted-by":"crossref","unstructured":"Alves NL, Hooibrink B, Arosa FA, van Lier RA. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood. 2003;102: 2541-2546.","DOI":"10.1182\/blood-2003-01-0183"},{"key":"2020021218315324300_REF54","unstructured":"Murphy GF. Cutaneous T-cell lymphoma. Adv Pathol. 1988;1: 131-156."},{"key":"2020021218315324300_REF55","doi-asserted-by":"crossref","unstructured":"Rook AH, Suchin KR, Kao DM, et al. Photopheresis: clinical applications and mechanism of action. J Invest Dermatol Symp Proc. 1999;4: 85-90.","DOI":"10.1038\/sj.jidsp.5640188"},{"key":"2020021218315324300_REF56","doi-asserted-by":"crossref","unstructured":"Krug A, Towarowski A, Britsch S, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001;31: 3026-3037.","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H"},{"key":"2020021218315324300_REF57","doi-asserted-by":"crossref","unstructured":"Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 1998;188: 2335-2342.","DOI":"10.1084\/jem.188.12.2335"},{"key":"2020021218315324300_REF58","doi-asserted-by":"crossref","unstructured":"Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol. 1996;157: 1840-1845.","DOI":"10.4049\/jimmunol.157.5.1840"},{"key":"2020021218315324300_REF59","doi-asserted-by":"crossref","unstructured":"Kranzer K, Bauer M, Lipford GB, Heeg K, Wagner H, Lang R. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology. 2000;99: 170-178.","DOI":"10.1046\/j.1365-2567.2000.00964.x"},{"key":"2020021218315324300_REF60","doi-asserted-by":"crossref","unstructured":"Van Uden JH, Tran CH, Carson DA, Raz E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur J Immunol. 2001;31: 3281-3290.","DOI":"10.1002\/1521-4141(200111)31:11<3281::AID-IMMU3281>3.0.CO;2-0"},{"key":"2020021218315324300_REF61","doi-asserted-by":"crossref","unstructured":"Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH. Depressed IL-12\u2013mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol. 1999;163: 4073-4079.","DOI":"10.4049\/jimmunol.163.7.4073"},{"key":"2020021218315324300_REF62","doi-asserted-by":"crossref","unstructured":"Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol. 2003;33: 119-124.","DOI":"10.1002\/immu.200390014"},{"key":"2020021218315324300_REF63","unstructured":"Dworacki G, Meidenbauer N, Kuss I, et al. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001;7: 947s-957s."},{"key":"2020021218315324300_REF64","unstructured":"Hoffmann TK, Dworacki G, Tsukihiro T, et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002;8: 2553-2562."},{"key":"2020021218315324300_REF65","unstructured":"Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res. 2000;6: 1351-1364."},{"key":"2020021218315324300_REF66","doi-asserted-by":"crossref","unstructured":"Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9: 669-676.","DOI":"10.1016\/S1074-7613(00)80664-0"},{"key":"2020021218315324300_REF67","doi-asserted-by":"crossref","unstructured":"Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191: 771-780.","DOI":"10.1084\/jem.191.5.771"},{"key":"2020021218315324300_REF68","doi-asserted-by":"crossref","unstructured":"Lodolce J, Burkett P, Koka R, et al. Interleukin-15 and the regulation of lymphoid homeostasis. Mol Immunol. 2002;39: 537-544.","DOI":"10.1016\/S0161-5890(02)00211-0"},{"key":"2020021218315324300_REF69","doi-asserted-by":"crossref","unstructured":"Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986;136: 4480-4486.","DOI":"10.4049\/jimmunol.136.12.4480"},{"key":"2020021218315324300_REF70","doi-asserted-by":"crossref","unstructured":"Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol. 1999; 162: 4511-4520.","DOI":"10.4049\/jimmunol.162.8.4511"},{"key":"2020021218315324300_REF71","doi-asserted-by":"crossref","unstructured":"Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97: 3146-3151.","DOI":"10.1182\/blood.V97.10.3146"},{"key":"2020021218315324300_REF72","doi-asserted-by":"crossref","unstructured":"Le Bon A, Etchart N, Rossmann C, et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol. 2003;4: 1009-1015.","DOI":"10.1038\/ni978"},{"key":"2020021218315324300_REF73","doi-asserted-by":"crossref","unstructured":"Cho HJ, Takabayashi K, Cheng PM, et al. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol. 2000;18: 509-514.","DOI":"10.1038\/75365"},{"key":"2020021218315324300_REF74","doi-asserted-by":"crossref","unstructured":"Blackwell SE, Krieg AM. CpG-A\u2013induced monocyte IFN-gamma\u2013inducible protein-10 production is regulated by plasmacytoid dendritic cell\u2013derived IFN-alpha. J Immunol. 2003;170: 4061-4068.","DOI":"10.4049\/jimmunol.170.8.4061"},{"key":"2020021218315324300_REF75","doi-asserted-by":"crossref","unstructured":"Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993;178: 1655-1663.","DOI":"10.1084\/jem.178.5.1655"},{"key":"2020021218315324300_REF76","doi-asserted-by":"crossref","unstructured":"Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science. 1993;262: 1059-1061.","DOI":"10.1126\/science.8235625"},{"key":"2020021218315324300_REF77","doi-asserted-by":"crossref","unstructured":"Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med. 2001;194: 1711-1719.","DOI":"10.1084\/jem.194.12.1711"},{"key":"2020021218315324300_REF78","doi-asserted-by":"crossref","unstructured":"Asadullah K, Haeussler-Quade A, Gellrich S, et al. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression. Exp Dermatol. 2000;9: 248-251.","DOI":"10.1034\/j.1600-0625.2000.009004248.x"},{"key":"2020021218315324300_REF79","doi-asserted-by":"crossref","unstructured":"Dobbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G. Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood. 1998;92: 252-258.","DOI":"10.1182\/blood.V92.1.252.413k08_252_258"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4142\/1704038\/zh802404004142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/4142\/1704038\/zh802404004142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T06:49:05Z","timestamp":1682750945000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/13\/4142\/18959\/Enhancement-of-the-host-immune-responses-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,15]]},"references-count":79,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-03-1190","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,15]]}}}